Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases

A composition, wherein said composition comprises each of elements a) to c) in the following amounts:

• a. An amount of +/−30% of from 243.8 mg to 731.4 mg of Omega-3 polyunsaturated fatty acids (PUFAs) EPA and DHA, in a weight ratio of EPA:DHA of from 1.2 to 1.8;
• b. An amount of +/−30% of from 12.5 mg to 37.5 mg of hydroxytyrosol;
• and
• c. An amount of +/−30% of from 40 mg to 120 mg of a non-formulated curcumin mixture;
• wherein the composition does not contain inhibitors of hepatic and intestinal glucuronidation such as piperine, and
• wherein if an excipient comprising lecithin is used, it does not form curcumin-phospholipid complexes wherein the w/w ratio of phospholipids with respect to curcumin is greater than 1.